Otavio Berwanger to Double-Blind Method
This is a "connection" page, showing publications Otavio Berwanger has written about Double-Blind Method.
Connection Strength
0.436
-
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021 09; 9(9):586-594.
Score: 0.100
-
Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial. JAMA. 2018 04 03; 319(13):1331-1340.
Score: 0.080
-
Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial. Am Heart J. 2018 04; 198:129-134.
Score: 0.078
-
A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial. Trials. 2011 Feb 24; 12:53.
Score: 0.049
-
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. N Engl J Med. 2021 07 29; 385(5):406-415.
Score: 0.025
-
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab. 2021 04; 23(4):886-896.
Score: 0.024
-
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med. 2019 04 18; 380(16):1509-1524.
Score: 0.021
-
Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial. J Hypertens. 2018 04; 36(4):933-938.
Score: 0.020
-
Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE). Can J Cardiol. 2018 03; 34(3):295-302.
Score: 0.020
-
Study protocol for the Balanced Solution versus Saline in Intensive Care Study (BaSICS): a factorial randomised trial. Crit Care Resusc. 2017 Jun; 19(2):175-182.
Score: 0.019